Trial Profile
Effect of sorafenib after allogeneic hematopoietic stem cell transplantation in FLT3-ITD-positive patients with acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 08 Apr 2015 New trial record